In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, ...

Abstract: The sizes of datasets in terms of the number of samples, features, and classes have dramatically increased in recent years. In particular, there usually exists a hierarchical structure among ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Another day, another AI mega raise. Ricursive Intelligence, a frontier AI lab, announced on Monday that it has raised $300 million in a Series A round of funding at a $4 billion valuation. Notably, ...

GopherJS compiles Go code (go.dev) to pure JavaScript code. Its main purpose is to give you the opportunity to write front-end code in Go which will still run in all browsers. Nearly everything, ...

Abstract: Training neural networks with the Moore–Penrose (MP) inverse has recently gained attention in view of its noniterative training nature. However, a significant drawback of learning based on ...